StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Acelyrin Inc (SLRN) PT Lowered to $6 at Citi
August 14, 2024 9:25 AM
Citi analyst Samantha Semenkow lowered the price target on Acelyrin Inc (NASDAQ: SLRN) to $6.00 (from $8.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Acelyrin Inc (SLRN) PT Lowered to $20 at Piper Sandler
August 14, 2024 8:15 AM
H.C. Wainwright Downgrades Acelyrin Inc (SLRN) to Neutral
August 14, 2024 6:13 AM
After-hours movers: Alphabet, Flutter Entertainment, DraftKings
August 13, 2024 4:57 PM
Acelyrin, Inc. (SLRN) Tops Q2 EPS by 22c
August 13, 2024 4:49 PM
Form 10-Q ACELYRIN, Inc. For: Jun 30
August 13, 2024 4:19 PM
Form 8-K ACELYRIN, Inc. For: Aug 09
August 13, 2024 4:15 PM
Acelyrin (SLRN) Reports Positive Phase 3 Data for Izokibep in Hidradenitis Suppurativa
August 13, 2024 4:00 PM
ACELYRIN, INC. Announces Positive Phase 3 Data for Izokibep in Hidradenitis Suppurativa; Focuses Strategy on Lonigutamab and Reports Second Quarter 2024 Financial Results
August 13, 2024 4:00 PM
Form SC 13G/A ACELYRIN, Inc. Filed by: FMR LLC
August 12, 2024 9:40 AM
